Xantomas eruptivos

Ana Laura Costa; César Chiappe; Luciana Cabral Campana

doi:10.47196/da.v29i2.2376

Authors

Ana Laura Costa José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
César Chiappe José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
Luciana Cabral Campana José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v29i2.2376

Keywords:

eruptive xanthomas, xanthomatosis, hypertriglyceridemia, hyperlipidemia

Abstract

Xanthomatosis is a disease characterized by lipid deposition in the skin and other organs and is due to primary or secondary hyperlipidemia. Xanthomas are yellowish skin tumors caused by deposition of lipoproteins inside tissue macrophages. Given this skin finding, it is essential to study the patient and family members to arrive at a diagnosis and thus avoid the complications associated with these disorders.

Author Biographies

Ana Laura Costa, José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Third Year Resident Physician, Dermatology Service, José María Ramos Mejía General Acute Hospital

César Chiappe, José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatopathologist, Dermatology Service, José María Ramos Mejía General Acute Hospital

Luciana Cabral Campana, José María Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Staff Physician in charge of the Autoimmune Blistering Diseases Sector, Stomatology Sector and Dermatology and Sexual Diversity Sector. Professor at the University of Buenos Aires (UBA), Dermatology Service, José María Ramos Mejía General Acute Hospital

References

I. Gámez Pérez L, Reig Macías I, Paredes Gutiérrez E, Castro Monteagudo C, et ál. Xantomas eruptivos. Causas, diagnóstico y tratamiento. Piel. 2011;26:505-507.

II. Pérez Martell T, Darías Domínguez C, Rodríguez Mena G, Negret Hernández M. Xantomas eruptivos: manifestación cutánea de desórdenes de las lipoproteínas. Presentación de un caso de un área de salud. Rev Med Electrón. [Seriada en línea] 2010;32(6). Disponible en URL: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/777/html [Consultado agosto 2023].

III. Loeckermann S, Braun-Falco M. Eruptive xanthomas in association with metabolic syndrome. Clin Exp Dermatol. 2010;35:565-566.

IV. Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158:181-188.

V. Chang HY, Ridky TW, Kimball AB, Hughes E, et ál. Eruptive xanthomas associated with olanzapine use. Arch Dermatol. 2003;139:1045-1048.

VI. Geyer AS, MacGregor JL, Fox LP, Rabinowitz A, et ál. Eruptive xanthomas associated with protease inhibitor therapy. Arch Dermatol. 2004;140:617-618.

VII. Sacchi A, Olivares L, Leiro V. Xantomatosis y dislipoproteinemias. Dermatol Argent. 2013;19:174-182.